Atlas Trials

Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19

Clinical trial NCT04551911 · COMPLETED

Trial details

NCT number
NCT04551911
Sponsor
OPKO Health, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19CoronavirusSARS-CoV2 Infection
Start date
2020-11-02
Primary completion
2021-10-08
Enrollment
171

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.